Literature DB >> 17236232

Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages.

Mayra Solis1, Raphaëlle Romieu-Mourez, Delphine Goubau, Nathalie Grandvaux, Thibault Mesplede, Ilkka Julkunen, Alessandra Nardin, Margarita Salcedo, John Hiscott.   

Abstract

Interferon (IFN) is an important effector of the innate immune response, induced by different viral or bacterial components through Toll-like receptor-dependent and -independent mechanisms. In human macrophages and macrophage-activated killer cells, we demonstrate that (i) the type I IFN response to lipopolysaccharide (LPS) is weak compared to the host response to virus infection; (ii) there is a temporal difference in the induction of tank-binding kinase-1 (TBK1) and IkappaB kinase (IKK)-related kinase epsilon (IKKepsilon) kinase activities in response to LPS, with TBK1 activated early and IKKepsilon induced in the late phase of IFN induction; and (iii) interferon regulatory factor (IRF)-7 is induced following LPS treatment, but there is no evidence that IRF-7 becomes activated by phosphorylation in vivo. Specifically, TBK1 kinase activity is rapidly increased after LPS stimulation (15 min) whereas IKKepsilon activation occurs at 8 h. RNA interference-mediated inhibition of TBK1 and IKKepsilon expression in macrophages interfere with IFNB and IRF7 gene expression following LPS activation. Macrophage priming with rIFN-alpha increased IRF-7 expression, led to a sharp up-regulation of the IFNB gene and to a rapid induction of IFNA2 upon LPS stimulation. These data support a differential role of TBK1 and IKKepsilon in the downstream response mediated by IRF-3 and IRF-7 to LPS in primary human macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236232     DOI: 10.1002/eji.200636090

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3.

Authors:  Alexa C Robitaille; Mélissa K Mariani; Audray Fortin; Nathalie Grandvaux
Journal:  J Vis Exp       Date:  2016-01-24       Impact factor: 1.355

2.  Ubiquitination of Innate Immune Regulator TRAF3 Orchestrates Expulsion of Intracellular Bacteria by Exocyst Complex.

Authors:  Yuxuan Miao; Jianxuan Wu; Soman N Abraham
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

3.  Individual interferon regulatory factor-3 thiol residues are not critical for its activation following virus infection.

Authors:  Nicolas Zucchini; Virginie Williams; Nathalie Grandvaux
Journal:  J Interferon Cytokine Res       Date:  2012-07-20       Impact factor: 2.607

4.  Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis.

Authors:  Deepa Hammaker; David L Boyle; Gary S Firestein
Journal:  Rheumatology (Oxford)       Date:  2011-05-25       Impact factor: 7.580

5.  An alternative model for type I interferon induction downstream of human TLR2.

Authors:  Timo Oosenbrug; Michel J van de Graaff; Mariëlle C Haks; Sander van Kasteren; Maaike E Ressing
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

6.  Myeloid-Specific Gene Deletion of Protein Phosphatase 2A Magnifies MyD88- and TRIF-Dependent Inflammation following Endotoxin Challenge.

Authors:  Lei Sun; Tiffany T Pham; Timothy T Cornell; Kelli L McDonough; Walker M McHugh; Neal B Blatt; Mary K Dahmer; Thomas P Shanley
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

7.  Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.

Authors:  Judith Olejnik; Adriana Forero; Laure R Deflubé; Adam J Hume; Whitney A Manhart; Andrew Nishida; Andrea Marzi; Michael G Katze; Hideki Ebihara; Angela L Rasmussen; Elke Mühlberger
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

8.  Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression.

Authors:  Anton Soucy-Faulkner; Espérance Mukawera; Karin Fink; Alexis Martel; Loubna Jouan; Yves Nzengue; Daniel Lamarre; Christine Vande Velde; Nathalie Grandvaux
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

9.  Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter.

Authors:  Suzanne Paz; Myriam Vilasco; Meztli Arguello; Qiang Sun; Judith Lacoste; Thi Lien-Anh Nguyen; Tiejun Zhao; Elena A Shestakova; Scott Zaari; Annie Bibeau-Poirier; Marc J Servant; Rongtuan Lin; Eliane F Meurs; John Hiscott
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

10.  The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.

Authors:  Anke Leichtle; Michelle Hernandez; Kwang Pak; Nicholas J Webster; Stephen I Wasserman; Allen F Ryan
Journal:  BMC Immunol       Date:  2009-08-05       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.